A simple image-analysis method is described, whereby the distribution of hepatocytes that have entered S-phase, as distinguished by the incorporation of bromodeoxyuridine, can be related to the position of the central and portal veins of the hepatic lobule. Hepatocyte S-phase was induced in the livers of male and female F344 rats by administration of di(2-ethylhexyl)phthalate (DEHP) in the diet for 7 days at 2 dose levels, and these livers were used to develop the procedure. The distributions of the S-phase between control and DEHP-treated livers were compared using statistical techniques. The results showed notable differences in the distribution of S-phase between male and female rats as well as limited dose-related effects.
INTRODUCTION
The cells of the hepatic lobule show well-described differences in terms of the distribution of many biochemical processes, such as those involved in the metabolism, activation, and detoxification of xenobiotics that enter the body (8, 24, 25) . Enzymes such as those of the cytochrome P-450 superfamily and the glutathione S-transferases are differentially distributed between the hepatocytes in proximity to the portal vein and those nearest the central vein (7, 10, 12, 20, 28) .
For those chemicals that are metabolized via these types of enzyme systems (i.e., acetaminophen, carbon tetrachloride, and sodium phenobarbitone), the toxicity and/or cellular change occur in those parts of the lobules containing the highest levels of the metabolizing enzyme systems (13, 14, 16, 26) . Hence, the position of the cells within the liver lobule is an important determinant in terms of the metabolizing enzymes contained within those cells.
Differences in the lobular distribution of hepatocytes undergoing DNA synthesis after the administration of different mitogenic chemicals have been recorded for a number of chemical classes. Peroxisome proliferators, for example, have generally been described as producing a periportal S-phase distribution (2, 3, 15) , whereas 1,4dichlorobenzene induces a centrilobular distribution of replicating cells (5) . Since hepatocytes in different regions of the liver lobule have very different metabolizing enzyme profiles, DNA synthesis, stimulated by a compound such as sodium phenobarbitone, occurring in the hepatocytes of the centrilobular area would be expected to take place in a very different environment than does DNA replication in a periportal hepatocyte. In the pres-ence of high levels of metabolic enzymes, either within the replicating cell itself or in the cells surrounding it, DNA synthesis may carry a greater risk than it does under other circumstances.
In the past, differences in the lobular distribution of Sphase cells have always been described in nominal terms, and although large increases in labeling indices can be ascribed a zonal distribution, low levels of induction and accurate dose-response relationships that may affect the distribution of the induced S-phase are difficult if not impossible to describe qualitatively. Considering the potential impact that differences in the zonal distribution of DNA synthesis could exert on the outcome of exposure to an hepatic mitogen, we have now developed a simple image-analysis procedure that enables us to obtain an accurate description of the zonal distribution of S-phase cells in the liver that can be compared in a statistical manner.
MATERIALS AND METHODS
Animals and Procedures. Male and female F344 rats that were 6-8 wk old (Harlan Olac Ltd., Bicester, UK) were acclimatized for 2 wk, housed 5 to a cage, and allowed free access to food (CT1 diet; Special Diet Services Ltd., Witham, UK) and filtered, sterilized water at all times. Temperature and relative humidity were held at 21 ± 2°C and 55 ± 5%, respectively.
After acclimatization, an osmotic minipump (Alza; Palo Alto, CA, USA) loaded with bromodeoxyuridine (BrdU; 15 mg/ml in phosphate-buffered saline) was implanted intrascapularly into each animal. Rats were fed either a normal diet or one containing di(2-ethylhexyl)phthalate (DEHP) at 6,000 or 12,000 ppm (Aldrich Chemical Co., Gillingham, UK). Each test group consisted of 10 rats of each sex, and the control group contained 20 animals of each sex. All animals were euthanatized with rising concentrations of carbon dioxide after FIG. 1.-The relationship of frequency and cumulative incidence data to morphologic or physiologic compartmentation of the liver lobule. A typical field for analysis is shown with the central vein (C) on the right and the portal vein (P) on the left; the portal and central veins are shown as shaded circles. The probable course of the portal blood flow is shown by the dotted lines from the portal vein, representing the midline of Rappaport's zone 1. 7 days' treatment. The livers were removed and a 2-3mm slice of the left median lobe was fixed in 10% neutral phosphate-buffered formalin for 7 days, dehydrated through ascending grades of ethanol, and processed through to paraffin wax. Sections (5-pLm thick) were cut onto glass slides, dewaxed, and stained for BrdU, using the method described previously (23) .
Analysis of BrdU-Labeled Hepatocytes.. The labeling index was assessed for each animal by counting the number of BrdU-labeled hepatocytes and the total number of hepatocytes in 5 randomly selected fields with a X 16 objective (using a computerized, semiautomatic image-analysis system) (23) , and values were expressed as a percentage. Group means were compared using a 2-sided Student's t-test. S-phase distribution was analyzed with a Leitz Orthoplan microscope and a Sony XC-77CE monochrome CCD video camera linked to a Kontron Vidas 2.1 imageanalysis system that was running on a 486DX 66-mHz computer (Imaging Associates, Thame, UK). Fields were selected that contained a portal and a central vein (clearly at the terminal lobular level and avoiding the periphery of the liver lobe). Using a X 16 objective, the central vein was placed at the center of the right side of the video screen, and the camera was rotated so that the portal vein was on the midline of the left side (Fig. 1 ). The imageanalysis procedure involved inputting this image, automatically selecting the BrdU-labeled cells based on their optical density, measuring the x and y coordinates of each BrdU-labeled hepatocyte, and collecting these coordi- nates in a database. In order to eliminate nonhepatocytes that were labeled with BrdU, a discriminatory step that was based upon the size and shape of the nuclei was inserted (23) . The portal vein x coordinate was interactively measured for each field. The x coordinates of each S-phase were adjusted in order to standardize the portal to central distance at 705 pixels. A minimum of 3 lobular fields were examined from each animal, with a minimum of 500 S-phase hepatocytes per group. A frequency histogram was displayed for the x coordinates of the BrdU-labeled hepatocytes; the height of each bin was adjusted so that the total number of S-phases for each group was in the same proportion as the labeling indices. The cumulative incidence of labeled cells from portal to central x coordinates was also calculated. The range of x coordinates between the central and portal veins was arbitrarily divided into 3 equal zones to represent periportal, midzonal, and centrilobular areas, and the percentage of S-phases in each zone was recorded.
Statistical Evaluations. Wilcoxon and log-rank tests were used to compare the cumulative incidence in each treated group with controls (11); the analyses were carried out in PROC LIFETEST in SAS (21) . As performed, the Wilcoxon test was designed to give more weight to differences in the central region, whereas the log-rank test gave more weight to differences in the portal region.
RESULTS

Estimated Received Dose
From the body weight and food consumption data, the estimated intakes for animals dosed with 6,000 ppm DEHP were 465 and 466 mg/kg body weight/day for males and females, respectively. For those animals dosed at 12,000 ppm DEHP, the estimated intakes were 922 and 972 mg/kg body weight/day for males and females, respectively. Therefore, at the higher dose, females received 5% more than males.
Hepatocyte Labeling Indices
The percentage of S-phase hepatocytes in untreated livers from female and male rats was 6.9 and 3.9%, respectively (Table I) . A statistically significant increase in the percentage of hepatocytes entering S-phase was seen in both sexes at both dose levels of DEHP for the 6,000and 12,000-ppm dose groups, respectively (Table I ).
There were no obvious differences in responses between males and females. TABLE IL-Changes in the lobular distribution of hepatocyte S-phase after dietary administration of DEHP to rats for 7 days.&dquo; 11 Summary statistics (mean ± SD) were weighted by the number of cells per animal. Owing to the variable and often low number of cells examined for controls, data were pooled within a group before carrying out the log-rank and Wilcoxon tests.
b Values are labeled hepatocytes in the region as a percentage of all labeled in the lobule; mean ± standard deviation. Table II shows the proportion of S-phase hepatocytes in each of the 3 designated zones of the liver lobule from the median lobe. In untreated male rats, the S-phase hepatocytes were equally distributed in the periportal and midzonal compartments of the hepatic lobule, with slightly fewer hepatocytes being present in the centrilobular compartment. Following dosing with DEHP, male rats showed a statistically significant shift in the distribution of hepatocytes in S-phase, such that there were fewer replicating cells in the centrilobular and midzonal compartments, with proportionately more hepatocytes being present in the periportal zone.
Lobular Distribution of BrdU-Labeled Hepatocytes
In untreated female rats, the S-phase hepatocytes were distributed in such a manner that a greater proportion were present in the centrilobular zone than in the other 2 zones, which displayed equal proportions of S-phase hepatocytes (Table II) . Following DEHP treatment, similar responses were seen with both dose levels. Although there was no statistically significant change in the distribution of S-phase hepatocytes in the livers of female rats, there was an increasing trend toward a midzonal distri- FIG. 2. -Frequency distribution, adjusted for labeling index, of BrdUlabeled hepatocytes from male F344 rats on a control diet, treated with DEHP at either 6,000 or 12,000 ppm for 7 days. The lobule fraction is calculated from the central vein (C = 0%) to the portal vein (P = 100%). The data for controls were pooled from 13 animals and for DEHP administered from 9 animals/group. bution (Table II and Figs. 2 and 3) and away from the predominantly centrilobular distribution present in the untreated female rat livers.
DISCUSSION
A simple and efficient image-analysis technique has been developed that allows for a quantitative comparison of S-phase distribution. The segmentation of the lobule into rectangular segments approximates the classically described periportal, midzonal, and centrilobular regions (27) . The reproduction of schemes such as those of Rappaport et al (18) , which more accurately describe the functional organization of the liver, on the randomly sectioned liver would be a subjective process and would be technically more complex, allowing little or no gain in terms of comprehensibility.
DEHP has been shown to be hepatocarcinogenic in both rats and mice (17) . The dose levels, route of administration, and strain of rat that we have used in our study are the same as those used in the long-term bioassay, in which neoplastic nodules and hepatic carcinomas developed in 12% of the rats following exposure to 6,000 ppm FIG. 3. -Frequency distribution, adjusted for labeling index, of BrdUlabeled hepatocytes from female F344 rats on a control diet, treated with DEHP at either 6,000 or 12,000 ppm. The lobule fraction is calculated from the central vein (C = 0%) to the portal vein (P = 100%). The data for controls were pooled from 11 animals and for DEHP administered from 10 animals/group. DEHP and in 25% of the rats after exposure to 12,000 ppm DEHP There was no marked sex difference in the carcinogenic response. Two putative markers for hepatocarcinogenicity of compounds that induce peroxisome proliferation have been suggested: the differential induction of catalase and the enzymes of (3-oxidation of fatty acids, which have been postulated to result in increased oxidative stress to the liver (19) , and the transient increase in hepatocyte S-phase, which takes place in the liver within the first week or so of exposure (15) . Neither marker has been conclusively demonstrated to have a clear-cut mechanistic link to neoplasia, although sustained increases in cell replication have been correlated with an increased cancer risk in a number of organs, including the liver (1, 6) .
The current investigation has described a shift in the lobular distribution of the induced hepatic DNA synthesis that occurs following exposure of rats to DEHP Chemically induced hepatic proliferation of peroxisomes has been shown to be differentially distributed across the liver lobule, at least at dose levels that are low enough to demonstrate selectivity (4, 9, 22) . The critical factor that determines a carcinogenic response of a chemical may not, therefore, simply be an overall induction of peroxisomes or of hepatic DNA synthesis but rather is selective induction of DNA synthesis in &dquo;high-risk&dquo; areas, or cells, of the liver, where metabolic activity, in some currently unknown way, may pose an increased chance that defect will occur during the process. This hypothesis would predict that the phenomenon of S-phase is not equal throughout the liver lobule and that S-phase in some areas carries a higher risk of a carcinogenic outcome, independent of the duration of the Sphase, than it does in low-risk areas where &dquo;metabolic stress,&dquo; for example, is lower. The hypothesis further predicts that these high-risk areas of the liver will be both compound and sex and strain dependent. The current studies allow the differential distribution of replicating cells to be accurately mapped and provide a means by which the hypothesis of selective cell targeting can be tested. Further work is currently underway to test the hypothesis using hepatic mitogenic compounds that are not hepatic carcinogens and to compare these compounds with chemicals that are both hepatic mitogens and carcinogens.
